Sofosbuvir

Paul A. Pham, Pharm.D., David L. Thomas, M.D., M.P.H., Janessa M. Smith, Pharm.D. BCPS
Sofosbuvir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of HCV genotype 1, 2, 3 or 4 as a component of a combination antiviral treatment regimen
  • Indicated in patients with hepatocellular carcinoma, those awaiting liver transplantation, and those with HCV/HIV-1 co-infection

NON-FDA APPROVED USES

  • In combination with an HCV active antiviral regimen, sofosbuvir’s (SOF) efficacy has been established in patients with HCV genotype 5 and 6

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 6, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Sofosbuvir ID - 540635 A1 - Pham,Paul,Pharm.D. AU - Thomas,David,M.D., M.P.H. AU - Smith,Janessa,Pharm.D. BCPS Y1 - 2017/04/06/ PB - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540635/all/Sofosbuvir ER -